Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BR-PROSPECT: Biotin Labeling for Platelet Evaluation
NCT07513532Phase 1Completed
- Sponsor
- Bloodworks Northwest
- Start
- Apr 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Bloodworks Northwest. Primary endpoint: Platelet Recovery and Survival at 12 days. Started Apr 2026; status: completed.
Beyond the preview
Go deeper on NCT07513532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07513532.